148 related articles for article (PubMed ID: 2825724)
1. Ribonucleotide reductase induced by varicella zoster virus. Characterization, and potentiation of acyclovir by its inhibition.
Spector T; Stonehuerner JG; Biron KK; Averett DR
Biochem Pharmacol; 1987 Dec; 36(24):4341-6. PubMed ID: 2825724
[TBL] [Abstract][Full Text] [Related]
2. Ribonucleotide reductase induced by herpes simplex type 1 virus. Characterization of a distinct enzyme.
Averett DR; Lubbers C; Elion GB; Spector T
J Biol Chem; 1983 Aug; 258(16):9831-8. PubMed ID: 6309786
[TBL] [Abstract][Full Text] [Related]
3. 2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (A1110U), a potent inactivator of ribonucleotide reductases of herpes simplex and varicella-zoster viruses and a potentiator of acyclovir.
Spector T; Harrington JA; Morrison RW; Lambe CU; Nelson DJ; Averett DR; Biron K; Furman PA
Proc Natl Acad Sci U S A; 1989 Feb; 86(3):1051-5. PubMed ID: 2536930
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of antiherpetic activity of acyclovir by ribonucleotide reductase inhibition.
Spector T; Averett DR; Nelson DJ; Lambe CU; Morrison RW; St Clair MH; Furman PA
Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4254-7. PubMed ID: 2987969
[TBL] [Abstract][Full Text] [Related]
5. Viral ribonucleotide reductase attenuates the anti-herpes activity of acyclovir in contrast to amenamevir.
Shiraki K; Tan L; Daikoku T; Takemoto M; Sato N; Yoshida Y
Antiviral Res; 2020 Aug; 180():104829. PubMed ID: 32569704
[TBL] [Abstract][Full Text] [Related]
6. Ribonucleotide reductase of herpes simplex virus type 2 resembles that of herpes simplex virus type 1.
Averett DR; Furman PA; Spector T
J Virol; 1984 Dec; 52(3):981-3. PubMed ID: 6092726
[TBL] [Abstract][Full Text] [Related]
7. Deletion of the varicella-zoster virus large subunit of ribonucleotide reductase impairs growth of virus in vitro.
Heineman TC; Cohen JI
J Virol; 1994 May; 68(5):3317-23. PubMed ID: 8151792
[TBL] [Abstract][Full Text] [Related]
8. Inactivators of herpes simplex virus ribonucleotide reductase: hematological profiles and in vivo potentiation of the antiviral activity of acyclovir.
Spector T; Lobe DC; Ellis MN; Blumenkopf TA; Szczech GM
Antimicrob Agents Chemother; 1992 May; 36(5):934-7. PubMed ID: 1324641
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of herpes simplex virus ribonucleoside diphosphate reductase by derivatives of 2-acetylpyridine thiosemicarbazone.
Turk SR; Shipman C; Drach JC
Biochem Pharmacol; 1986 May; 35(9):1539-45. PubMed ID: 3011019
[TBL] [Abstract][Full Text] [Related]
10. Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus.
Earnshaw DL; Bacon TH; Darlison SJ; Edmonds K; Perkins RM; Vere Hodge RA
Antimicrob Agents Chemother; 1992 Dec; 36(12):2747-57. PubMed ID: 1336346
[TBL] [Abstract][Full Text] [Related]
11. Herpes and human ribonucleotide reductases. Inhibition by 2-acetylpyridine 5-[(2-chloroanilino)-thiocarbonyl]-thiocarbonohydrazone (348U87).
Spector T; Harrington JA; Porter DJ
Biochem Pharmacol; 1991 Jun; 42(1):91-6. PubMed ID: 1648925
[TBL] [Abstract][Full Text] [Related]
12. Herpes simplex virus type 1 ribonucleotide reductase: selective and synergistic inactivation by A1110U and its iron complex.
Porter DJ; Harrington JA; Spector T
Biochem Pharmacol; 1990 Feb; 39(4):639-46. PubMed ID: 2154988
[TBL] [Abstract][Full Text] [Related]
13. Vaccinia virus-induced ribonucleotide reductase can be distinguished from host cell activity.
Slabaugh MB; Mathews CK
J Virol; 1984 Nov; 52(2):501-6. PubMed ID: 6387174
[TBL] [Abstract][Full Text] [Related]
14. Herpes simplex virus ribonucleotide reductase mutants are hypersensitive to acyclovir.
Coen DM; Goldstein DJ; Weller SK
Antimicrob Agents Chemother; 1989 Aug; 33(8):1395-9. PubMed ID: 2552912
[TBL] [Abstract][Full Text] [Related]
15. Effects of ribonucleotide reductase inhibition on pyrimidine deoxynucleotide metabolism in acyclovir-treated cells infected with herpes simplex virus type 1.
Karlsson A; Harmenberg J
Antimicrob Agents Chemother; 1988 Jul; 32(7):1100-2. PubMed ID: 2847642
[TBL] [Abstract][Full Text] [Related]
16. Characterization of ribonucleotide reductase induction in BHK-21/C13 Syrian hamster cell line upon infection by herpes simplex virus (HSV).
Langelier Y; Buttin G
J Gen Virol; 1981 Nov; 57(Pt 1):21-31. PubMed ID: 6172549
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of mammalian ribonucleotide reductase by a dinucleotide produced in eucaryotic cells.
Lewis WH; McNaughton DR; Goh SH; LéJohn HB; Wright JA
J Cell Physiol; 1977 Dec; 93(3):345-52. PubMed ID: 338619
[TBL] [Abstract][Full Text] [Related]
18. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
Suzuki M; Okuda T; Shiraki K
Antiviral Res; 2006 Nov; 72(2):157-61. PubMed ID: 16797734
[TBL] [Abstract][Full Text] [Related]
19. The effects of interferon-alpha and acyclovir on herpes simplex virus type-1 ribonucleotide reductase.
O'Brien WJ; Narasimhan J; Guy J; Tom P; Taylor JL
Antiviral Res; 1998 May; 38(2):107-16. PubMed ID: 9707373
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of plaque formation of herpes simplex virus (HSV) and varicella-zoster virus (VZV) by subinhibitory dose of acyclovir (ACV).
Shiraki K; Miyaki C; Namazue J; Yamanishi K; Takahashi M
Acta Virol; 1989 Dec; 33(6):565-8. PubMed ID: 2576598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
